Ortho Evra Label Update Includes Study Data On Blood Clot Risk
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA requests J&J conduct longer follow up studies on the risk of serious blood clots, heart attack and stroke associated with the birth control patch.
You may also be interested in...
Ortho Evra Adds More Blood Clot Warnings To Label
New epidemiology study supports previous findings of increased venous thromboembolism risk with J&J’s birth control patch.
Ortho Evra Adds More Blood Clot Warnings To Label
New epidemiology study supports previous findings of increased venous thromboembolism risk with J&J’s birth control patch.
J&J's Evra Canadian Label Includes Obesity, Sauna Warnings
Revised labeling on risk of venous thromboembolism associated with the birth control patch in Canada appears stronger than FDA's revision on Ortho Evra.